These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The efficacy of hepatoprotective agents in experimental chronic hepatitis].
    Author: Saratikov AS, Vengerovskiĭ, Baturina NO, Chuchalin VS.
    Journal: Eksp Klin Farmakol; 1996; 59(1):24-6. PubMed ID: 8704626.
    Abstract:
    Hepatoprotective drugs eplyr, essential, salsocollin, macsar and legalon in rats with chronic CCl4 hepatosis prevent fibrosis development, inflammatory infiltration of portal tracts, dystrophia and hepatocytes necrosis, reduce the content of hepatic glycoseaminoglycanes, oxyproline and different collagenic fractions in liver, weaken manifestations of cytolytic and cholestatic syndromes, improve antitoxic hepar function.
    [Abstract] [Full Text] [Related] [New Search]